BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31595650)

  • 1. ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.
    Louphrasitthiphol P; Chauhan J; Goding CR
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):112-118. PubMed ID: 31595650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
    Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
    Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
    Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
    Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
    Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cells initiating human melanomas.
    Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
    Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In melanoma, beta-catenin is a suppressor of invasion.
    Arozarena I; Bischof H; Gilby D; Belloni B; Dummer R; Wellbrock C
    Oncogene; 2011 Nov; 30(45):4531-43. PubMed ID: 21577209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.
    Sana G; Madigan JP; Gartner JJ; Fourrez M; Lin J; Qutob N; Narayan J; Shukla S; Ambudkar SV; Xia D; Rosenberg SA; Gottesman MM; Samuels Y; Gillet JP
    J Invest Dermatol; 2019 Sep; 139(9):1985-1992.e10. PubMed ID: 30905807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
    Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
    PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
    Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
    J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J; Ondrušová L
    Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
    Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
    J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
    Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
    Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
    Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
    J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 15. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
    Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
    J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pathways activated in melanocytes and melanoma.
    Liu J; Fukunaga-Kalabis M; Li L; Herlyn M
    Arch Biochem Biophys; 2014 Dec; 563():13-21. PubMed ID: 25109840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.
    Bell RE; Levy C
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1088-106. PubMed ID: 22004179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
    Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
    Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
    Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
    Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.